Refer Me

Get ReferralsAI ApplyTailor ResumeFor YouPremium
Sign in
Korro Bio

Korro Bio

Cambridge, Massachusetts, United States

501-1000 Employees

Healthcare Tech

Director, Analytical Development

60 First St, Cambridge, US

Posted on Jan 8, 2026

Full TimeExecutiveHybridR & D

Job Description

Company Summary: Korro is a biopharmaceutical company focused on developing a new class of genetic medicines for both rare and highly prevalent diseases using its proprietary RNA editing platform. Korro is generating a portfolio of differentiated programs that are designed to harness the body’s natural RNA editing process to effect a precise yet transient single base edit. By editing RNA instead of DNA, Korro is expanding the reach of genetic medicines by delivering additional precision and tunability, which has the potential for increased specificity and improved long-term tolerability. Using an oligonucleotide-based approach, Korro expects to bring its medicines to patients by leveraging its proprietary platform with precedented delivery modalities, manufacturing know-how, and established regulatory pathways of approved oligonucleotide drugs. Korro is based in Cambridge, Massachusetts.

We are collaborative and united by a common mission. We are building a company with extraordinary people with an audacious vision to create transformative genetic medicines for prevalent diseases. Our values - Rewrite the future, On the Cutting Edge, Better Together, Dynamically Different, Kindness and Integrity form the fabric of the organization. They are reinforced daily and serve as key dimensions in the hiring process to help us ensure that Korro is a magnet for outstanding talent and a great place to work. Join us as we redefine what's possible in genetic medicine and work to make a lasting impact on human health.

Position Summary: Korro Bio is seeking a passionate, self-motivated, and talented leader with a background in oligonucleotide therapeutics to join our Analytical Development team within CMC function. In this key role, you will be leading for all aspects of analytical development related to both drug substance and drug product components of the modalities. The successful candidate will be responsible for the deployment of methods for routine analysis of oligonucleotides to advance our RNA editing drug discovery platform and programs. The successful candidate will play a key role in advancing a pipeline of products from the early stage drug development to market approval. Success will require leadership across a matrixed analytical organization, effective collaboration with other CMC functions, close management of CDMO activities, and significant contribution to the overall CMC strategy for the program. Deep knowledge of cGMPs and regulatory guidelines, significant experience in the CMC development of oligonucleotide and considerable expertise in the analytical techniques and strategies commonly used in the development of oligonucleotides is essential. Candidate must express a high attention to details, be comfortable multitasking in a fast-paced startup environment.   

About Korro Bio

Korro Bio is a biotechnology company focused on developing novel gene editing technologies to advance precision medicine and transform the treatment of genetic diseases. Founded in 2018, Korro Bio's innovative approaches have the potential to revolutionize the field of genetic medicine and bring about new therapeutic solutions for patients worldwide.

Job overview

Employment type

Full Time

Experience level

Executive

Work type

Hybrid

Department

R & D

Posted

on Jan 8, 2026

About

Job Link

jobs.lever.co

Financials

Type

public

Annual Revenue

--

Market Cap

$225.6M+

Subscribe to Refer Me premium to get referred to this role at Korro Bio!

Your career is worth investing in.

Get unlimited referrals with Premium.

Upgrade to Premium

Refer Me logo

Refer Me

Referrals

Get Referred

Subscription

© 2026 Crucible Fund LLC. All rights reserved.